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Abstract
Cardiac progenitor cells are multipotent
stem cells isolated from both embryonic and
adult hearts in several species and are able to
differentiate at least into smooth muscle cells,
endothelial cells and cardiomyocytes. The
embryonic origin of these cells has not yet
been demonstrated, but it has been suggested
that these cells may derive from the first and
secondary heart fields and from the neural
crest. In the last decade, two different popula-
tions of cardiac progenitor or stem cells have
been identified and isolated, i.e., the Islet1
positive (Isl1+) and c-Kit positive (c-
Kit+)/Stem Cell Antigen-1 positive (Sca-1+)
cells. Until 2012, these two populations have
been considered two separate entities with dif-
ferent roles and a different origin, but new evi-
dence now suggests a connection between the
two populations and that  the two populations
may represent two subpopulations of a unique
pool of cardiac stem cells, derived from a com-
mon immature primitive cell. To find a com-
mon consensus on this concept is very impor-
tant in furthering the application of stem cells
to cardiac tissue engineering. 
Islet1 positive cells duringheart development
At the end of 2003, the research group of
Prof. Evans, using a mouse mutant for the LIM
homeodomain transcription factor (Islet1,
Isl1), demonstrated that an Isl1 positive
(Isl1+) population is localised in the secon-
dary heart field (SHF), contributing to the out-
flow tract, right ventricle, atria and (to a small
extent) the left ventricle.1 Isl1 is considered a
marker of SHF cells that contribute to the
venous and arterial poles of the cardiac tube,
while the other cells from the SHF contribute
only to the arterial pole.2 The SHF or anterior
heat field (AHF) was identified as a splanchnic
mesoderm underlying  the caudal pharynx,
which provides myocardium to the outflow
tract during tube looping.3,4 In 2005, the
same research group also identified Isl1+/c-Kit
negative (c-Kit-)/Stem Cell Antigen-1 negative
(Sca-1-) progenitors in the post-natal heart,
demonstrating that these cells persist after
birth and that these organ-specific progenitor
cells may be isolated, purified, expanded and
differentiated into mature cardiac myocytes
for future cardiac applications.  
Our research group identified Isl1+ cells
during gestation until the postnatal age, and
demonstrated the contemporary expression of
Isl1 and c-Kit in the interstitial cells in the ven-
tricular myocardium in human foetal and post-
natal hearts.  This paper demonstrated, by
confocal analysis, that all Isl1+ cells were also
c-Kit+, while c-Kit+ cells were not necessarily
Isl1+, as if Isl1+ cells were a subpopulation of
c-Kit+ cells.5
It has been supposed that there may be a
primordial cardiovascular precursor in the SHF
that expresses the three markers Isl1, Nkx2.5
and Fetal Liver Kinase 1 (flk1) and can genera-
te three lineages: cardiac muscle, smooth
muscle and endothelium.6 The SHF cooperates
with the first heart field (FHF) and the cardiac
neural crest cells during the development of
the vertebrate heart.7 The FHF lineage forms
the early cardiac tube and generates the left
ventricle, while the SHF contributes additional
cells to the maturing heart and, along with the
cardiac neural crest cells, generates the out-
flow tract vessels and valves.8
The presence of cardiovascular progenitor
cells positive for Isl1 and/or Nkx2.5 in the SHF
has been  well confirmed by a recent work
published in Science.9 The authors suggested
that there are two distinct populations, one for
the SHF and the other for the FHF; the first
population is clearly positive for Isl1 and
expresses miRNA 199a/b, while the second has
no distinct markers and expresses miRNA
200a/b. Progenitor cells of the SHF depend on
the cardiac specific transcription factors Isl1
and Nkx2.5, which play a key role at an early
stage of cardiac progenitor formation. Their
expression is regulated by Wnt/beta-catenin
signalling, which in turn also regulates Bmp4
signalling.10 This last signalling pathway acti-
vates Gata4 and SRF.8 Despite the key role of
Isl1, this transcription factor is not considered
an indubitable marker of this subpopulation of
SHF progenitor cells. It has been demonstrated
very recently that Isl1 labels both SHF precur-
sors and some cardiac neural crest cells and
that Mef2C is a more efficient marker of the
SHF progenitor cells in labelling experi-
ments.11 This paper indirectly suggests both a
review of past literature in view of these new
data and using a different marker in studies of
the SHF progenitor cells. Moreover, conside-
ring heart development in different species,
such as chicken, mouse and Xenopus, it
appears that Isl1 is expressed in a common
cardiac cell population that splits into FHF and
SHF lineages during heart development and
that this common progenitor also contributes
cells to the cardiovascular system.12
Isl1 positive cells in the adultheart
Since September 2003, when Prof. Anversa’s
research group described rat cardiac stem cells
for the first time,13 many research groups have
claimed to have discovered new and important
cardiac progenitor/stem cells in the adult
heart.14. Since 2005, the scientific community
talked about adult c-Kit+ and/or Sca-1+ and/or
MDR-1+ cells, and embryonic Isl1+ cells.
These two populations have always been consi-
dered different entities and are described
separately in many research papers and
reviews,15-17 although expression of the Isl1
transcription factor by cardiac precursor cells
has also been reported in adult hearts.  
Our research group, in the same time as the
research group of Prof. Di Nardo, described for
the first time the concomitant expression of
the three markers, i.e., c-Kit, Sca-1 and Isl1, in
the same cardiac precursor cell. Prof. Di
Nardo’s research group described the concomi-
tant expression of the Isl1, c-Kit and Sca-1
markers in adult mouse cardiac progenitor
cells in 2008,18 while in 2009 our research
group confirmed the expression of the three
markers in adult rat CPCs.19 In a systematic
work published in 2011 about the identifica-
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tion of Isl1+ cells in the mouse heart from
postnatal day 1 to young adulthood in different
strains, the authors found clusters of positive
cells in the cardiac ganglia of the studied
strains, while found very a few clusters of Isl1+
cardiac precursors only in 129SvJ or Balb/C
strains and in animals not older than 4
months.20
Recently Genead et al.21 demonstrated the
contemporary expression of c-Kit and Isl1
markers in rat adult hearts in normal, pre-
gnant and infarcted individuals. They reported
the expression of both markers in the entire
heart and in the right ventricle, the left ventri-
cle, the outflow tract and the peri-infarct and
peri-ischemia regions. Unfortunately, the
study was based on real-time PCR analysis,
and whenever immunocytochemistry was
shown, no double staining for both markers
had been performed. Other evidence supports
the hypothesis that Isl1+ cells are not a diffe-
rent population from Sca-1+ CPCs. The con-
temporary expression of Sca-1 and Isl1 has
been described both in a subpopulation of Sca-
1+/c-Kit- cells identified and isolated from
adult mouse hearts22 and in Sca-1+ cardio-
sphere-derived cells obtained from cardiac
explants from normal, sham-operated or post-
myocardial infarct hearts.23 In this study, only
Sca-1+/CD45- cells were also positive for Isl1
and increased in number only after an acute
myocardial infarct.23
Considering that other authors identified
Isl1+ cells in adult murine and rat hearts,
Weinberger et al.24 used heterozygous Isl1-
LacZ mice, a more sensitive genetic approach,
to investigate the presence and localisation of
these precursor cells in 30 animals at different
time points after birth (10 weeks to 18
months).
They found four different populations of
Isl1+ cells: i) clusters of Isl1+ neurons were
found in the cardiac parasympathetic ganglia
of the posterior side of the heart and in the
nervous plexus surrounding the pulmonary
veins; ii) clusters of Isl1+ smooth muscle cells
were found in the muscular layer above the
aortic and pulmonary valve in the proximal
part of the aorta and the trunk of the pulmo-
nary artery (only a few positive cells were pre-
sent in the aortic valve leaflets); iii) clusters of
Isl1+ cardiomyocytes were found in the left
ventricular outflow tract region; iv) clusters of
Isl1+ sinoatrial node (SAN) cells were found in
the muscular wall between right atrium and
vena cava superior.
These results support the hypothesis that in
the adult heart many cell populations may deri-
ve from Isl1+ embryonic precursors, as smooth
muscle cells, parasympathetic neurons, SAN
cells, but also that, even if reduced in number,
Isl1+ cardiomyogenic progenitors, may be pre-
sent in the adult myocardium.  
Concluding remarks
Many papers have been published on CPCs,
and many research groups claimed to have
discovered different populations of progenitor
cells. It is strange to think that the cardiac tis-
sue possesses a large number of stem/progeni-
tor cells compared to the other tissues found in
our body, and it is hopeful that CPCs may vary
in number with external stimuli or with age as
it happens for other adult stem cells.25,26 The
hypothesis that the myocardium is a non-rege-
nerative tissue is not valid any more, and
much evidence supports the new idea that
there is at least one cardiac progenitor cell. 
Isl1+ and c-Kit+/Sca-1+ cells were conside-
red to be two different populations until 2012,
when Prof. Sussmann, citing our recent paper
published in the European Journal of
Histochemistry5 in an editorial in Circulation
Research, suggested considering the possibi-
lity of studying a population of cells positive for
both Isl1 and c-Kit instead of choosing to study
only one side of the coin.27 In the review14 and
in the research paper19 published in 2009, we
reported the concomitant expression of Isl1, c-
Kit and Sca-1 in a population of CPCs isolated
without any sorting or selection and suggested
for the first time that there could be  a unique
population of cells with several subpopulations
and that the several markers identified could
be only the effect of different cultivation condi-
tions in the different laboratories. Other
research groups later described the co-expres-
sion of Isl1, Sca-1 and/or c-Kit21,22 and we
further demonstrated that, in samples from
foetal and postnatal human hearts, there was
also an Isl1+ subpopulation of c-Kit+ cells.5
Finally, in January 2012 a paper was publi-
shed, with Prof. Anversa among the authors,
on a study of the presence of c-Kit+ cardiac
stem cells in embryonic, foetal and neonatal
mouse hearts.28 They demonstrated that these
cells can form cardiomyocytes and coronary
vessels and, as we have demonstrated in our
paper, they are more abundant than Isl1+ cells.
Moreover,  they stated that Isl1+ cells are pre-
sent only in the outflow tract, atria and part of
the right ventricle and that they are a popula-
tion of committed cells derived from an imma-
ture primitive cell. 
We can say that there is strong evidence
suggesting that c-Kit, Sca-1 and Isl1 may be
markers of subpopulations of CPCs that are
present in the embryonic, foetal and neonatal
heart and persist from after birth until
adulthood.  The identification of the real
immature cardiac precursor expressing the
four cell markers (c-Kit, Sca-1, MDR-1 and
Isl1) and above all the identification of a uni-
que isolation protocol is very important in the
clinical practice. This immature common car-
diac precursor may represent the perfect can-
didate for cardiac tissue engineering and,
hopefully, may be driven pharmacologically to
one phenotype or the other. To identify a stan-
dardised protocol is extremely important to go
further in the studies on cardiac tissue rege-
neration, and common guidelines are needed
in cardiac stem cell therapy. The isolation of
stem cells by cell sorting or immunobead selec-
tion using surface markers such as c-Kit, Sca-
1 or MDR-1 is important to identify a standar-
dised protocol of isolation, however Isl1 may be
useful in basic research to follow the fate of
CPCs in heart development and myocardium
differentiation.
Moreover, it is extremely important to
understand which is the predominant precur-
sor population in the different stages of life
and which population should be used in a pae-
diatric patient instead of an adult one. If fate of
immature cardiac precursors may be determi-
ned pharmacologically, the possibility to rege-
nerate SAN cells is very important in curing
arrhythmia’s both in patients with ischemia
and malformations. 
The identification of the different subpopu-
lations in the developing heart may be a funda-
mental step in identifying the optimal cell line
for cell-based therapies.
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